WHOLIHAN EDWARD 4
4 · Allena Pharmaceuticals, Inc. · Filed Dec 18, 2020
Insider Transaction Report
Form 4
WHOLIHAN EDWARD
Chief Financial Officer
Transactions
- Sale
Common Stock
2020-12-17$1.36/sh−68,550$93,228→ 121,272 total - Exercise/Conversion
Restricted Stock Units
2020-12-17−164,822→ 0 total→ Common Stock (164,822 underlying) - Exercise/Conversion
Common Stock
2020-12-17+164,822→ 189,822 total
Footnotes (3)
- [F1]The sale reported on this Form 4 was effected by the Reporting Person and represents shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units
- [F2]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F3]On December 2, 2019, the Reporting Person was granted 82,411 restricted stock units, vesting in two equal installments on June 2, 2020 and December 2, 2020 (the "December 2019 Grant"). On May 28, 2020, the reporting person was granted an additional 82,411 restricted stock units (the "May 2020 Grant") and the December 2019 Grant was amended to vest in full, together with the May 2020 Grant, on December 2, 2020. 164,822 shares of common stock were distributed to the Reporting Person on December 17, 2020 following the vesting of the restricted stock units from the December 2019 Grant and the May 2020 Grant.